SNX15 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.671200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.445600E-01
Normal-vs-Stage2
8.952000E-01
Normal-vs-Stage3
1.122410E-01
Normal-vs-Stage4
9.290400E-01
Stage1-vs-Stage2
1.404200E-01
Stage1-vs-Stage3
8.982300E-02
Stage1-vs-Stage4
3.737000E-01
Stage2-vs-Stage3
2.716400E-02
Stage2-vs-Stage4
7.868600E-01
Stage3-vs-Stage4
1.263990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.332600E-01
Normal-vs-AfricanAmerican
9.292200E-01
Normal-vs-Asian
9.563800E-01
Caucasian-vs-AfricanAmerican
8.845200E-01
Caucasian-vs-Asian
7.997200E-01
AfricanAmerican-vs-Asian
9.741800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.429200E-01
Normal-vs-Female
8.633400E-01
Male-vs-Female
9.616600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.484410E-01
Normal-vs-Age(41-60Yrs)
6.978800E-01
Normal-vs-Age(61-80Yrs)
7.052200E-01
Normal-vs-Age(81-100Yrs)
7.273200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.341980E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.812600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.073400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.460700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.986430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.833600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.308200E-01
Normal-vs-Daily Drinker
9.497800E-01
Normal-vs-Weekly Drinker
9.346600E-01
Normal-vs-Occasional Drinker
6.475600E-01
Normal-vs-Social Drinker
8.684400E-01
Non Drinker-vs-Daily Drinker
1.011200E-01
Non Drinker-vs-Weekly Drinker
2.696000E-01
Non Drinker-vs-Occasional Drinker
1.681990E-02
Non Drinker-vs-Social Drinker
1.616030E-01
Daily Drinker-vs-Weekly Drinker
7.962400E-01
Daily Drinker-vs-Occasional Drinker
4.687800E-01
Daily Drinker-vs-Social Drinker
7.179400E-01
Weekly Drinker-vs-Occasional Drinker
3.852800E-01
Weekly Drinker-vs-Social Drinker
9.995000E-01
Occasional Drinker-vs-Social Drinker
2.358000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.948800E-01
Normal-vs-Grade 2
9.489600E-01
Normal-vs-Grade 3
9.350800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.232200E-01
Grade 1-vs-Grade 3
3.268000E-01
Grade 1-vs-Grade 4
9.948800E-01
Grade 2-vs-Grade 3
6.932400E-01
Grade 2-vs-Grade 4
9.489600E-01
Grade 3-vs-Grade 4
9.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.404800E-01
Normal-vs-NonDiabetic
9.852600E-01
Diabetic-vs-NonDiabetic
2.698200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.728000E-01
Normal-vs-NoPancreatitis
8.306000E-01
Pancreatitis-vs-NoPancreatitis
6.756100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.573400E-01
Normal-vs-N1
9.147800E-01
N0-vs-N1
5.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.914400E-01
Normal-vs-TP53-NonMutant
9.565600E-01
TP53-Mutant-vs-TP53-NonMutant
2.105900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
